# HORIZANT
> **NDA022399** · New Drug Application · Sponsor: AZURITY · Approved 2011-04-06
## Drug
- **FDA Application Number:** NDA022399
- **Application type:** New Drug Application
- **Brand name:** HORIZANT
- **Generic name:** GABAPENTIN ENACARBIL
- **Active ingredients:** GABAPENTIN ENACARBIL
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- **First approval:** 2011-04-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022399)
---
*MORVS · CC0 1.0*